Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Zynerba Pharma CS (ZYNE)

6.23 -0.11 (-1.74%)

9/22/2017  4:00pm

Open:

6.36

Pre. Close:

6.34

High:

6.37

Low:

6.09

Volume:

563,094

Market Cap:

82.59M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.5 - 6.57

6.57 - 6.77

Low:

5.6 - 5.71

5.71 - 6.06

Close:

5.83 - 5.97

5.97 - 6.39

Technical analysis  (as of: 2017-09-22 4:46:12 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 7.45     One year: 8.00

Support:

Support1: 5.62    Support2: 4.68

Resistance:

Resistance1: 6.38    Resistance2: 6.85

Pivot:

6.31

Moving Averages:

MA(5): 6.33     MA(20): 6.29

MA(100): 14.09     MA(250): 16.07

MACD:

MACD(12,26): -0.74     Signal(12,26,9): -1.03

%K %D:

%K(14,3): 29.25     %D(3): 33.75

RSI:

RSI(14): 33.39

52-Week:

High: 23.57  Low: 6.09  Change(%): -55.6

Average Vol(K):

3-Month: 80983  10-Days 11939

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ZYNE has closed above bottom band by 20.6%. Bollinger Bands are 93.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ZYNE's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 19 Jan 2017 16:48:29 GMT
Why Zynerba Pharmaceuticals Inc. Is Tanking Today

Mon, 07 Aug 2017 10:41:15 GMT
Zynerba Pharmaceuticals Announces Top-Line Results from Phase 2 STAR 1 Trial ...

Fri, 28 Jul 2017 11:26:15 GMT
Zynerba Pharmaceuticals Mourns Passing of Director Cynthia A. Rask

Fri, 02 Jun 2017 17:24:12 GMT
What Zynerba Pharmaceuticals does

Mon, 14 Aug 2017 10:41:15 GMT
Zynerba Pharmaceuticals Announces that Results from Phase 2 STOP Trial Support ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

13.26

Shares Float (M)

10.61

% Held by Insiders

20.21

% Held by Institutions

37.23

Shares Short (K)

2800

Shares Short Prior Month (K)

2730

Stock Financials

EPS

-2.600

EPS Est. Current Year

-2.420

EPS Est. Next Year

-2.410

EPS Est. Next Quarter

-0.580

Forward EPS

-2.405

Book Value (p.s.)

5.370

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-31.3

Return on Equity (ttm)

-55.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.001

Sales Per Share

EBITDA (p.s.)

-2.161

Qtrly Earnings Growth

Operating Cash Flow (M)

-26.41

Levered Free Cash Flow (M)

-13.79

FoxReading.com

Valuation

P/E

-2.40

P/E Growth Ratio

-0.02

P/BV

1.16

P/S

P/CF

-3.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.